Hemp-derived Products Testing Agency: Compliance Must be Fulfilled

Market

Mar.05.2023

ACS Laboratories emphasized the need for compliance with regulations governing hemp-derived products.

David, Fort Lauderdale - On the 2nd day of the APE show, 2FIRSTS carried out random interviews to gather insights on hemp products compliance.

One of the interviewees, staff from the compliance testing institute ACS Laboratories, emphasized the need for compliance with regulations governing hemp-derived products. ACS Laboratories ensures that the products they test are legal and safe, which requires the products to contain no more than the legally allowed amount of THC and no heavy metals, pesticides, mycotoxins, pathogenic microbiology, etc. After the testing, their results will be printed on the labeling of the products.

To start a business in Florida, said ACS Laboratories, you need to get a license through the Department of Agriculture (USDA) and make sure you are running everything according to their guidelines. Every state has its own guidelines approved by the USDA.

#Europe #Open system e-cigarettes #United Kingdom #Products #Regulation #Drug testing #Product

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner

State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner

As the U.S. vapor market faces FDA authorizations, import seizures and growing state-level restrictions, AVM President Allison Boughner told 2Firsts that state product registries and white-list systems are having the most immediate impact. She said distributors are placing greater weight on documentation, product origin and supply-chain transparency.

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

According to Investing.com citing Bank of America scanner data for the four weeks ending May 30, U.S. nicotine category performance was mixed, with cigarette, vapor and cigar sales declining while oral tobacco sales rose 5.8%.

U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion

U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion

An opinion article published by Stars and Stripes argued that the Pentagon’s January nicotine clinical guidelines overemphasize abstinence, fail to reflect the reality that about 30% of active-duty personnel use nicotine, and do not address nicotine pouches as potential harm-reduction products.

Industry Insight

FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews

FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews

The U.S. Food and Drug Administration released a programmatic environmental assessment covering nicotine pouches and other oral nicotine products, concluding that their overall environmental impact is generally minimal.

Special Report｜U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window

Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.

Industry Insight

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco

U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.

Related Topics

Related Read

State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner

State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%

U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion

U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion

FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews

FDA Posts Environmental Assessment for Nicotine Pouches, May Influence Future PMTA Reviews

Special Report｜U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco